CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 54326-54707 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T389","span":{"begin":0,"end":381},"obj":"Sentence"},{"id":"T63242","span":{"begin":0,"end":381},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Adverse effects were graded according to the VCOG-CTCAE grading system (grade 1 alopecia, n = 2; grade 1 combined neutropenia and lymphopenia, n = 2; grade 1 lymphopenia, n = 1; grade 1 lethargy, n = 1; grade 2 gastrointestinal signs, n = 1; grade 2 injection site reaction, n = 1; grade 2 hypersensitivity, n = 1; grade 4 hypersensitivity, n = 1; grade 5 hypersensitivity, n = 1)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T254","span":{"begin":80,"end":88},"obj":"Disease"},{"id":"T255","span":{"begin":114,"end":125},"obj":"Disease"},{"id":"T256","span":{"begin":130,"end":141},"obj":"Disease"},{"id":"T257","span":{"begin":158,"end":169},"obj":"Disease"},{"id":"T258","span":{"begin":290,"end":306},"obj":"Disease"},{"id":"T260","span":{"begin":323,"end":339},"obj":"Disease"},{"id":"T262","span":{"begin":356,"end":372},"obj":"Disease"},{"id":"T56973","span":{"begin":80,"end":88},"obj":"Disease"},{"id":"T71139","span":{"begin":114,"end":125},"obj":"Disease"},{"id":"T59889","span":{"begin":130,"end":141},"obj":"Disease"},{"id":"T25587","span":{"begin":158,"end":169},"obj":"Disease"},{"id":"T27404","span":{"begin":290,"end":306},"obj":"Disease"},{"id":"T42631","span":{"begin":323,"end":339},"obj":"Disease"},{"id":"T36131","span":{"begin":356,"end":372},"obj":"Disease"}],"attributes":[{"id":"A254","pred":"mondo_id","subj":"T254","obj":"http://purl.obolibrary.org/obo/MONDO_0004907"},{"id":"A255","pred":"mondo_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/MONDO_0001475"},{"id":"A256","pred":"mondo_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A257","pred":"mondo_id","subj":"T257","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A258","pred":"mondo_id","subj":"T258","obj":"http://purl.obolibrary.org/obo/MONDO_0000605"},{"id":"A259","pred":"mondo_id","subj":"T258","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A260","pred":"mondo_id","subj":"T260","obj":"http://purl.obolibrary.org/obo/MONDO_0000605"},{"id":"A261","pred":"mondo_id","subj":"T260","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A262","pred":"mondo_id","subj":"T262","obj":"http://purl.obolibrary.org/obo/MONDO_0000605"},{"id":"A263","pred":"mondo_id","subj":"T262","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A55165","pred":"mondo_id","subj":"T56973","obj":"http://purl.obolibrary.org/obo/MONDO_0004907"},{"id":"A3004","pred":"mondo_id","subj":"T71139","obj":"http://purl.obolibrary.org/obo/MONDO_0001475"},{"id":"A23244","pred":"mondo_id","subj":"T59889","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A97250","pred":"mondo_id","subj":"T25587","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A3491","pred":"mondo_id","subj":"T27404","obj":"http://purl.obolibrary.org/obo/MONDO_0000605"},{"id":"A44683","pred":"mondo_id","subj":"T27404","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A35786","pred":"mondo_id","subj":"T42631","obj":"http://purl.obolibrary.org/obo/MONDO_0000605"},{"id":"A10015","pred":"mondo_id","subj":"T42631","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A3192","pred":"mondo_id","subj":"T36131","obj":"http://purl.obolibrary.org/obo/MONDO_0000605"},{"id":"A38689","pred":"mondo_id","subj":"T36131","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"}],"text":"Adverse effects were graded according to the VCOG-CTCAE grading system (grade 1 alopecia, n = 2; grade 1 combined neutropenia and lymphopenia, n = 2; grade 1 lymphopenia, n = 1; grade 1 lethargy, n = 1; grade 2 gastrointestinal signs, n = 1; grade 2 injection site reaction, n = 1; grade 2 hypersensitivity, n = 1; grade 4 hypersensitivity, n = 1; grade 5 hypersensitivity, n = 1)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T160","span":{"begin":80,"end":88},"obj":"Phenotype"},{"id":"T161","span":{"begin":114,"end":125},"obj":"Phenotype"},{"id":"T162","span":{"begin":130,"end":141},"obj":"Phenotype"},{"id":"T163","span":{"begin":158,"end":169},"obj":"Phenotype"},{"id":"T164","span":{"begin":186,"end":194},"obj":"Phenotype"}],"attributes":[{"id":"A160","pred":"hp_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/HP_0001596"},{"id":"A161","pred":"hp_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/HP_0001875"},{"id":"A162","pred":"hp_id","subj":"T162","obj":"http://purl.obolibrary.org/obo/HP_0001888"},{"id":"A163","pred":"hp_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/HP_0001888"},{"id":"A164","pred":"hp_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/HP_0001254"}],"text":"Adverse effects were graded according to the VCOG-CTCAE grading system (grade 1 alopecia, n = 2; grade 1 combined neutropenia and lymphopenia, n = 2; grade 1 lymphopenia, n = 1; grade 1 lethargy, n = 1; grade 2 gastrointestinal signs, n = 1; grade 2 injection site reaction, n = 1; grade 2 hypersensitivity, n = 1; grade 4 hypersensitivity, n = 1; grade 5 hypersensitivity, n = 1)."}